Global Key SolutionsGKS
Guidance Documents/Guidance-Document/Nontuberculous Mycobacterial Pulmonary Disease Caused by Mycobacterium avium Complex: Developing Drugs for Treatment : Guidance for Industry

Nontuberculous Mycobacterial Pulmonary Disease Caused by Mycobacterium avium Complex: Developing Drugs for Treatment : Guidance for Industry

Detailed guidance document from FDA and regulatory agencies.

Document Details

Guidance Document

September 5, 2023

September 5, 2023

Center for Drug Evaluation and Research

dda15f98-e807-4823-898a-ad26150481d1

Related Documents

Smallpox (Variola Virus) Infection: Developing Drugs for Treatment or Prevention Guidance for Industry

Guidance DocumentNovember 18, 2019Center for Drug Evaluation and Research
View Details →

Eosinophilic Esophagitis: Developing Drugs for Treatment Guidance for Industry

Guidance DocumentSeptember 15, 2020Center for Drug Evaluation and Research
View Details →

Vulvovaginal Candidiasis: Developing Drugs for Treatment

Guidance DocumentAugust 1, 2019Center for Drug Evaluation and Research
View Details →

Quick Actions

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
[email protected]
Quick Links
KeyPedia™ Lite
Legal & Ethics
©2026, Global Key Solutions All rights reserved.